Independent Laboratory Billing of Automated Multi-Channel Chemistry (AMCC) Organ Disease Panel Laboratory Tests for Beneficiaries who are not Receiving Dialysis for Treatment of End Stage Renal Disease (ESRD)
This change request (CR) sunsets the requirement for Independent Labs to bill separately for each individual AMCC lab test included in organ disease panel codes for ESRD eligible beneficiaries.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: August 01, 2011
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.